Ausgabe 2/2017
Inhalt (8 Artikel)
Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer
Khalid El Bairi, Abdul Hafeez Kandhro, Adel Gouri, Wafaa Mahfoud, Noureddine Louanjli, Brahim Saadani, Said Afqir, Mariam Amrani
microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells
Anusha Sathyanarayanan, Karthik Subramanian Chandrasekaran, Devarajan Karunagaran
HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation
Suresh Bugide, Vijay Kumar Gonugunta, Vasudevarao Penugurti, Vijaya Lakshmi Malisetty, Ratna K. Vadlamudi, Bramanandam Manavathi
CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer
Sayantan Bhattacharyya, Vasanthakumar Sekar, Biswanath Majumder, Debapriya G Mehrotra, Samir Banerjee, Anup K Bhowmick, Neyaz Alam, Gautam K Mandal, Jaydip Biswas, Pradip K Majumder, Nabendu Murmu
microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression
Guang-Cheng Guo, Jia-Xiang Wang, Ming-Li Han, Lian-Ping Zhang, Lin Li
Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells
Maria Saveria Gilardini Montani, Marisa Granato, Claudio Santoni, Paola Del Porto, Nicolò Merendino, Gabriella D’Orazi, Alberto Faggioni, Mara Cirone
Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis
M. Giulietti, G. Occhipinti, G. Principato, F. Piva
ELMO3 expression indicates a poor prognosis in head and neck squamous cell carcinoma - a short report
Lorenz Kadletz, Gregor Heiduschka, Robert Wiebringhaus, Elisabeth Gurnhofer, Ulana Kotowski, Georg Haymerle, Markus Brunner, Conor Barry, Lukas Kenner